Jason K. Sicklick, M.D., FACS

Professor/Principal Investigator
University of California, San Diego
La Jolla, California, United States

Disclosure information not submitted.

Presentation(s):

• Welcome Foundational Science of Sarcomas Symposium

  Wednesday, November 13, 2024
  8:00 AM – 8:05 AM PST

• Paper 12 - FIRST-IN-HUMAN PERSONALIZED, N-OF-1 COMBINATION THERAPIES FOR ADVANCED GASTROINTESTINAL STROMAL TUMORS

  Thursday, November 14, 2024
  10:30 AM – 11:30 AM PST

• Paper 14 - SELECTIVE INTERNAL RADIATION THERAPY FOR SUCCINATE DEHYDROGENASE DEFICIENT GASTROINTESTINAL STROMAL TUMORS DEMONSTRATES ENCOURAGING DURABLE RESPONSE RATES: AN INTERNATIONAL MULTICENTER CASE SERIES

  Thursday, November 14, 2024
  10:30 AM – 11:30 AM PST

• Paper 38 - DEFINING NOVEL BENCHMARK VALUES FOR OUTCOMES OF COMPREHENSIVE RESECTION OF PRIMARY RETROPERITONEAL LIPOSARCOMA

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Paper 59 - PERK MEDIATED ENDOPLASMIC RETICULUM (ER) STRESS ACTIVATION IS A KEY MODULATOR OF TMZ-INDUCED ACTIVATION OF THE DR-5 IN SUCCINATE DEHYDROGENASE (SDH)-DEFICIENT GASTROINTESTINAL STROMAL TUMOR (GIST)

  Friday, November 15, 2024
  2:00 PM – 3:00 PM PST

• Paper 65 - A NOVEL MOLECULAR RISK SCORE FOR ESTIMATING GIST RISK OF RECURRENCE

  Friday, November 15, 2024
  4:00 PM – 5:00 PM PST